Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show Post author: Post published:April 23, 2024 Post category:uncategorized Tafenoquine, a prodrug that could fulfill the criteria for a mass eradication campaign. You Might Also Like New stem cell therapy for heart failure undergoing U.S. clinical trials August 7, 2024 Unraveling the role of ADGRF5: Insights into kidney health and function June 21, 2024 TB preventive treatment delivers real-world gains for people with HIV August 17, 2026